Siegel Adam, Adam Richard, Rubner Rhianna, Bains Henrietta, Ha Richard, Maldjian Takouhie
Department of Radiology, Montefiore Medical Center/Albert Einstein College of Medicine, 111 E 210th Street, Bronx, NY 10467, USA.
New York Medical College. 40 Sunshine Cottage Rd, Valhalla, NY 10595, USA.
Radiol Case Rep. 2024 Jun 17;19(9):3729-3731. doi: 10.1016/j.radcr.2024.05.045. eCollection 2024 Sep.
Ipsilateral axillary adenopathy post-COVID mRNA vaccine has been widely reported and guidelines for management have been established. Isolated changes of axillary tail trabecular thickening without associated adenopathy in the breast present a diagnostic dilemma and no official guidelines have thus far been reported. This finding has been reported after COVID mRNA vaccine and has never been reported with any other vaccine. We report on a patient with such changes on screening mammography 1.5 months after the fifth dose of a COVID-mRNA vaccine and 1 week after RSV vaccine. This raises the possibility that such changes can be seen with vaccines other than the COVID mRNA series of vaccines. The main differential diagnosis includes mastitis and inflammatory breast cancer. The transient nature of this finding with spontaneous resolution at diagnostic mammography and the vaccination history helps to establish the diagnosis and exclude breast cancer.
新冠mRNA疫苗接种后同侧腋窝淋巴结病已被广泛报道,并且已经制定了管理指南。乳腺中孤立的腋窝尾部小梁增厚而无相关淋巴结病的变化带来了诊断难题,迄今为止尚无官方指南报道。这一发现已在新冠mRNA疫苗接种后被报道,而在其他任何疫苗接种后均未被报道。我们报告了一名患者,在接种第五剂新冠mRNA疫苗1.5个月后和接种RSV疫苗1周后,乳腺钼靶筛查出现了此类变化。这增加了在新冠mRNA系列疫苗以外的其他疫苗接种后出现此类变化的可能性。主要鉴别诊断包括乳腺炎和炎性乳腺癌。这一发现的短暂性,在诊断性乳腺钼靶检查时自发消退,以及接种疫苗史有助于确立诊断并排除乳腺癌。